Eugene C. Tarne
Senior AnalystEugene C. Tarne is a senior analyst with the Charlotte Lozier Institute. He is also the president of Tarne Communications Inc., a communications and issue advocacy company he founded in 1999. For more than 25 years, beginning in 1989, Mr. Tarne served as a communications and media relations consultant to the United States Conference of Catholic Bishops Secretariat for Pro-Life Activities. In this capacity, he works closely with the Pro-Life Secretariat to develop messages, promote issues and legislation, develop new programs and materials and implement communications strategies designed to educate the public and promote pro-life issues in the public square. These issues include abortion, assisted suicide and euthanasia, and bioethical issues, especially cloning and stem cell research. In 1996, Mr. Tarne helped found the Physicians Ad Hoc Coalition for Truth (PHACT), an organization of doctors and other medical professionals formed to bring the medical facts to bear on the partial-birth abortion debate. Mr. Tarne also served as Communications Director for Do No Harm: The Coalition of Americans for Research Ethics, a coalition of scientists, researchers, bioethicists, medical, academic and other professionals, patient advocates, and concerned individuals, established in 1999, to promote the ethical pursuit of stem cell research and regenerative medicine in general, and to provide accurate information on such research. Mr. Tarne graduated from Georgetown University in 1977 with a B.A. in Theology. He received his M.A. in History of Religions from The George Washington University in 1979. He was offered scholarships to Harvard, the University of Chicago and the University of Pennsylvania to pursue a Ph.D. in South Asian Studies. He attended the University of Chicago and later the University of Pennsylvania, where he completed his Ph.D. studies, except for dissertation.
Research Authored
Dr. Yamanaka’s Nobel Prize a Victory for Ethical Stem Cell Research
The Nobel Prize for MedicineĀ awarded to Japanās Shinya YamanakaĀ last month is a thoroughly deserved recognition of his groundbreaking work in regenerative medicine, work that just five years ago forever changed the way stem cell research is conducted around the globe.
The Trend Towards Ethical Stem Cell Success Continues
Two recent developments involving the California Institute for Regenerative Medicine (CIRM) again serve to underscore the reality that adult and other non-embryonic avenues of stem cell research are advancing at a far more dramatic pace toward providing actual therapeutic benefits for patients than is human embryonic stem cell research (hESCR).
No Run on this Bank
It would seem that the California Institute for Regenerative Medicine (CIRM) is not alone as it increasingly moves away from human embryonic stem cell research (hESCR) and towards adult and other non-embryonic avenues of stem cell research.
Fetal Pain and a Benevolent Society
The Subcommittee on the Constitution of the U.S. House Judiciary Committee in 2012 held a hearing on legislation that would ban abortions in the District of Columbia after 20 weeks fetal gestation, based on the ability of the fetus to experience pain at that point and beyond.
Assisted Suicide in Oregon: Evidence of Missed Evaluation for Depression
As required by law, the Public Health Department of the Oregon Health Authority has released itsĀ annual reportĀ for 2011 on physician-assisted suicides under that stateāsĀ Death with Dignity ActĀ (DWDA).
The Dark Ladder of Logic: After-Birth Abortion
TheĀ Journal of Medical EthicsĀ (JME) is one of those highly specialized, relatively expensive publications that cater to a targeted group of professionals.Ā Because these journals are expensive (a print/onlineĀ U.S. annual subscriptionĀ for theĀ JMEĀ is $431) and have such a very specific audience, they are rarely read by laypeople outside the professional circles they are intended to address. Unless such a journal publishes an article online endorsing infanticide.
From Standard Medical Practice to Rape
This March, Virginia became the eighth state to require that some form of ultrasound be performed for women seeking an abortion and that the woman be given the option to view the resulting image and hear any audible fetal heartbeat.